·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
µ¶ÀÚÁ¦º¸
Event
´º½º
Àüü±â»ç
Á¤Ã¥ · ¹ý·ü
Á¦¾à · ¹ÙÀÌ¿À
¾à±¹ · º´¿ø
Ä«µå´º½º
ÆÊTV
À̽´¿µ»ó
DPÃÊ´ë¼®
À̽´Áø´Ü
¾Ë¾Æº¸Àâ
¿ÀÇǴϾð
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
±âÀÚ¼öø
Ưº°±â°í
English
Policy
Opinion
Company
Product
Interview
TVÆÊµµ¶ó
ÆÊTube
ÆÊ¼îÇÎ
³ª´Â¾à»ç´Ù
ÆÊµå¶ó¸¶
ÆÊ¾ÆÄ«µ¥¹Ì
ÃʽÉŬ·¡½º
OTC»ó´ã
Á¦Ç°°ÁÂ
Çмú°ÁÂ
°æ¿µ°ÁÂ
Ä¿¹Â´ÏƼ
ÆÊ¸®Äí¸£Æ®
ä¿ëÁ¤º¸
PHARMARCY
ÀÎÀçÁ¤º¸
DPºÎµ¿»ê
¾à±¹ Q&A
¾à»ç´ëÃâ
¾à»ç½Å¿ë´ëÃâ
¼¼¹«»ó´ã
¼¼¹«·³ë¹«
¹ý·ü»ó´ã
¾à±¹°æ¿µ°úâ¾÷
ÀǾàÀÚ·á½Ç
ÀǾàÇàÁ¤
¾à»ç¾à±¹
ÀǷẴ¿ø
Á¦¾àÀ¯Åë
º¸µµÀÚ·á
ÆÊ½ºÅ¸Å¬·´
ÀÎ»ç · ºÎÀ½
¾à±¹ÀåÅÍ
ȸ»ç¼Ò°³
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
»ç¾÷Á¦ÈÞ
ÀÎÅͳݽŹ®À±¸®°·É
µ¶ÀÚÁ¦º¸
±âÀÚÀ±¸®°·É
ÀÚÀ²¼¾à¼
¿ø°ÝÁö¿ø¿äû
Event & ¼¼¹Ì³ª
Àüü±â»ç
±×·¡ÇÈ
Á¤Ã¥¡¤¹ý·ü
Á¦¾à¡¤¹ÙÀÌ¿À
¾à±¹¡¤º´¿ø
±âȹ¡¤Å½»ç
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
񃯇
񃯇
ÀǾàǰ
³¹¾Ë½Äº°
µ¥Àϸ®ÆÊ Live Search
´Ý±â
´º½º
>
Àüü ±â»ç
Àüü Çìµå¶óÀÎ ±â»ç
Àüü
|
03-08 (Åä)
|
03-07 (±Ý)
|
03-06 (¸ñ)
|
03-05 (¼ö)
|
03-04 (È)
|
03-03 (¿ù)
|
03-02 (ÀÏ)
ûÁֽþà, ÀǾàǰ ǰÀý¡¤È¸¼ö ´ëÀÀ À§ÇÑ Á¦¾àÀ§¿øÈ¸ ½Å¼³
2025-03-05 17:20:40
[µ¥Àϸ®ÆÊ=±èÁöÀº ±âÀÚ] ÃæºÏ ûÁֽþà»çȸ(ȸÀå ±èÂùÀÏ)´Â 4ÀÏ ÃæºÏ¾à»çȸ°ü¿¡¼ 2025³âµµ ÃʵµÀÌ»çȸ¸¦ ¿°í ¿ÃÇØ ȸ¹« ¹æÇâ°ú »ç¾÷°èȹÀ» ÀǰáÇÏ°í ±âŸ ¾È°Ç, °ÇÀÇ...
±èÁöÀº ±âÀÚ
±èÀç±³ Çѹ̻çÀ̾𽺠ºÎȸÀå, Çѹ̾àǰ ÀÌ»çȸµµ ÁøÀÔ
2025-03-05 17:13:10
[µ¥Àϸ®ÆÊ=Â÷ÁöÇö ±âÀÚ] Çѹ̾àǰ±×·ì ÁöÁÖ»ç ´ëÇ¥·Î ³»Á¤µÈ ±èÀç±³ Çѹ̻çÀ̾𽺠°æ¿µÃѰý ºÎȸÀåÀÌ Çѹ̻çÀÌ¾ð½º¿Í Çѹ̾àǰ ÀÌ»çȸ¿¡ µ¿½Ã ÁøÀÔÇÑ´Ù. 5ÀÏ ±ÝÀ¶...
Â÷ÁöÇö ±âÀÚ
ÈÀÌÀÚ, »õ ±âÀü JAK ¾ïÁ¦Á¦ Ãâ½Ã¡¦ÁßÁõ¿øÇüÅ»¸ð ½ÃÀå °ø·«
2025-03-05 15:59:18
[µ¥Àϸ®ÆÊ=Ȳº´¿ì ±âÀÚ] Çѱ¹ÈÀÌÀÚ°¡ »õ·Î¿î ¾ß´©½º Ű³ª¾ÆÁ¦(JAK) ¾ïÁ¦Á¦ÀÎ ¸®Æ®Ç®·Î(¸®Æ®·¹½ÃƼ´ÕÅä½Ç»ê¿°)¸¦ Ãâ½ÃÇϸç ÁßÁõ ¿øÇüÅ»¸ðÁõ ½ÃÀå °ø·«¿¡ ³ª¼±´Ù. ¾Õ...
Ȳº´¿ì ±âÀÚ
Á¦ÀÏ, Çѽ¼ö ȸÀå Â÷³² ÀÌ»ç ¼±ÀÓ¡¦3¼¼ ÇüÁ¦ ÀÌ»çȸ ÁøÀÔ
2025-03-05 15:29:51
[µ¥Àϸ®ÆÊ=Â÷ÁöÇö ±âÀÚ] Çѽ¼ö Á¦ÀϾàǰ ȸÀå Â÷³²ÀÌ ¿À´Â Á¤±â ÁÖÁÖÃÑȸ¿¡¼ ÀÌ»çȸ¿¡ ÁøÀÔÇÑ´Ù. ÀÌ·Î½á ¿À³Ê°¡ 3¼¼ µÎ ÇüÁ¦°¡ ³ª¶õÈ÷ µî±âÀ̻翡 ¿À¸£°Ô µÆ´Ù. 5...
Â÷ÁöÇö ±âÀÚ
ÃÖ ´ëÇà, ÀÇÁ¤°¥µî ¼Ó 'ÀÇ·á°³Çõ' ÀÇÁö¡¦"°ú°¨È÷ ¹ý °³Á¤"
2025-03-05 13:30:23
[µ¥Àϸ®ÆÊ=ÀÌÁ¤È¯ ±âÀÚ] ÃÖ»ó¸ñ ´ëÅë·É ±ÇÇÑ´ëÇàÀÌ Áö¿ª¡¤ÇʼöÀÇ·á °È¸¦ À§ÇÑ ÀÇ·á°³Çõ ¿Ï¼ö¸¦ À§ÇØ ¹üÁ¤ºÎ Â÷¿øÀÇ °·ÂÇÑ Á¤Ã¥¡¤ÀÔ¹ý Áö¿ø°ú ÇÔ²² ÀçÁ¤ ÅõÀÚ¿¡ ³ª...
ÀÌÁ¤È¯ ±âÀÚ
"´ÙÀÌ¼Ò Àú°¡ °Ç±â½Ä ´ë¾È ¸¶·Ã"¡¦ÆÊÇÁ·»Áî, 30ÀÏ ¼¼¹Ì³ª
2025-03-05 12:55:00
[µ¥Àϸ®ÆÊ=±èÁöÀº ±âÀÚ] ÆÊÇÁ·»Áî(ȸÀå ¾ç´ö¼÷)°¡ ÃÖ±Ù ºÒ°ÅÁø »ýȰÀâÈÁ¡ ´ÙÀ̼ÒÀÇ Àú°¡ °Ç±â½Ä ÆÇ¸Å¿Í °ü·Ã Áö¿ª ¾à±¹ÀÇ ´ëÀÀ ¹æ¾ÈÀ» °í¹ÎÇÏ´Â ÀÚ¸®¸¦ ¸¶·ÃÇÑ´Ù. ...
±èÁöÀº ±âÀÚ
Àü¹®¼º ´õÇÏ´Â Çѱ¹·Î½´¡¦'Ç×¾ÏÁ¦¡¤½ºÆä¼ÈƼ' ¸®´õ½Ê °È
2025-03-05 12:33:27
[µ¥Àϸ®ÆÊ=Ȳº´¿ì ±âÀÚ] Çѱ¹·Î½´°¡ °íÇü¾Ï¡¤Ç÷¾×¾Ï Ç×¾ÏÁ¦(Oncology¡¤Hematology) Ŭ·¯½ºÅÍ¿Í ½ºÆä¼ÈƼ ÀǾàǰ(Specialty Medicines) Ŭ·¯½ºÅÍ¿¡ ½ÅÀÓ ¸®µå¸¦ ¼±ÀÓÇÏ...
Ȳº´¿ì ±âÀÚ
Çѱ¹³ëº¸³ëµð½ºÅ©, ij½ºÆÛ ·Î¼¼À¯ Æ÷¿ï¼¾ ½ÅÀÓ ´ëÇ¥ ¼±ÀÓ
2025-03-05 12:26:55
[µ¥Àϸ®ÆÊ=Ȳº´¿ì ±âÀÚ] Çѱ¹ ³ëº¸ ³ëµð½ºÅ©Á¦¾àÀº 2025³â 3¿ùºÎÅÍ Ä³½ºÆÛ ·Î¼¼À¯ Æ÷¿ï¼¾(Kasper Roseeuw Poulsen)À» ½ÅÀÓ ´ëÇ¥ÀÌ»ç(General Manager)·Î ¼±ÀÓÇÑ´Ù°í 5...
Ȳº´¿ì ±âÀÚ
ºó´Ù¸Æ½º, ATTR-CM ¼ºÀÎ ´ë»ó °Ç°º¸Çè ±Þ¿© Àû¿ë
2025-03-05 12:12:55
[µ¥Àϸ®ÆÊ=Ȳº´¿ì ±âÀÚ] Çѱ¹ÈÀÌÀÚÁ¦¾àÀº Á¤»óÇü(wild type) ¶Ç´Â À¯Àü¼º Æ®·£½ºÆ¼·¹Æ¾ ¾Æ¹Ð·ÎÀÌµå ½É±Ùº´Áõ (ÀÌÇÏ ATTR-CM) Ä¡·áÁ¦ ºó´Ù¸Æ½º(ŸÆÄ¹Ìµð½º)°¡ °Ç°º¸Çè...
Ȳº´¿ì ±âÀÚ
±¹»ê¿ø·á ¾´ ±¹°¡Çʼö¾à 68% °¡»ê¡¦ÃÖ´ë 10³â Àû¿ë
2025-03-05 12:10:23
[µ¥Àϸ®ÆÊ=ÀÌÁ¤È¯ ±âÀÚ] ±¹»ê ¿ø·á¸¦ ½á¼ ¸¸µç ±¹°¡ÇʼöÀǾàǰ(Á¦³×¸¯)¿¡ 68% ¾à°¡°¡»êÀ» Àû¿ëÇÏ´Â Á¦µµ°¡ Áö³ 4ÀϺÎÅÍ ½ÃÇàµÆ´Ù. °¡»ê ±â°£Àº 5³âÀ¸·Î, ÃÖÃÊ °¡...
ÀÌÁ¤È¯ ±âÀÚ
1
2
3
4
5
ä¿ë
¼Óº¸
ÁÖ¹®½Ã °áÁ¦±Ý¾×ÀÇ 5% Áï½Ã ÇÒÀÎ!
[»ïÇö] ¼Òµ¶¿ë¿¡Åº¿Ã
5%
760¿ø
ºí·¢¾Þ°Å½º LA²É°¥ºñ ¼±¹°¼¼Æ®
79%
53,500
[Çϸ²] ¿ë°¡¸® ġŲ³Ê°Ù 1+1
38%
17,005¿ø
µå¸²ÀÌÀ½ ¾ËÆÄ½ÃŬ·Î µ¦½ºÆ®¸° ´ÙÀÌ·ºÆ® ¾ËÆÄ
35%
11,000
È«»ïÁ¤ ¿¡ºê¸®Å¸ÀÓ ·Õ±â½ºÆ®
65%
31,900
[¿À¶óƽ½º] ±¸°À¯»ê±Õ 5°³¿ùºÐ
62%
85,500¿ø
¹Ù¸£´Â ÆÄ½º Ä𸵠½ºÆ÷Ã÷°Ö
5%
9,500¿ø
[¸ÅÁ÷½¦ÇÁ] ¹Ì´Ï Á¦½À±â
37%
35,625
¹Ì¶óŬÅ彺 ¾îµå¹ê½ºµå ÆäÀÌ¼È Å¬·»Àú
50%
27,500
[¶ó¿¤] À¯±â³ó ¼ø¸é »ý¸®´ë
34%
5,605¿ø
ÀÓ»êºÎ ¸®Æ÷ÆÛ ¾×»ó öºÐÁ¦
50%
15,000
ÄÚÄÚ½ºÅ丮 360 ¸¶±×³×½· ½ºÇÁ·¹ÀÌ
42%
7,000
µ¿¿øÂüÄ¡ Á¾ÇÕ A1È£
30%
17,500
[Á¤°üÀå] Àå»ý±âº¸ 30Æ÷
50%
149,000
[¿À¶óƽ½º] ÀÓÇöõƽ½º 5°³¿ùºÐ
61%
118,750¿ø
¾ß»ý ºôº£¸®&¶óÁ¸® 6ÆÑ
25%
32,300¿ø
¿Ãµ¥ÀÌ KF94 ¸¶½ºÅ©
8%
250¿ø
µ¿¿ø °Ç°ÇÑÂüÄ¡ ¼±¹°¼¼Æ®
30%
35,500
[¾¾¸®¾ó¸¶ÄÏ] ¹Ù»èÇÑ ¼ÓÃÊ ¸ÔÅÂ
46%
18,900
¹Ì¶óŬÅ彺 ¾îµå¹ê½ºµå ¸®ÇÁÆÃ ¾ÚÇÃ
50%
44,000
¾ÆÀÌ¿ø Ŭ¸®³Ê¼¼Á¤ 20¸ÅÀÔ
12%
88,825¿ø
NEW ûÁ¤¿ø Á¤¼º12È£
37%
17,900
°üÀý¿£ ö°©»ó¾î&¼Ò¿¬°ñ Äܵå·ÎÀÌÄ£ ¹ÂÄÚ´Ù´ç´Ü¹é
26%
14,700
Çã´Ï¿¡¼¾½º ¸®À¯ÀúºíÄÅ ²Ü ¼±¹°¼¼Æ®
29%
34,300
¾Ë¸² ¡¤ °øÇ¥
±³À° ¡¤ °ÁÂ
¾à±¹ Q&A
Á¢¼ö ¡¤ ¹®ÀÇ
¾Ë¸²
ÆÊ½ºÅ¸Å¬·´ ·ê·¿ÄíÆù ¡æ ÆÊÆ÷ÀÎÆ® ±³È¯ À̺¥Æ® GO ¢º
°øÇ¥
JW½Å¾à ÀǾàǰ(³ª¹«Á¹Á¤) ȸ¼ö¿¡ °üÇÑ °øÇ¥
¾Ë¸²
½Å°³³ä »êÁ¦Çü ¸Ö¹Ì¾à, ½ºÅä¸Ö»ê! POP & ¹æ¹®½Åû ¢º
¾Ë¸²
ÄÉÅäÅé ½Ã¿øÇÑ ÄðÆÄ½º ½Å±Ô Ãâ½Ã!! ¿µ»ó º¸·¯ GO ¢º
°øÇ¥
(ÁÖ)ÆÊÁ¨»çÀ̾𽺠ÀǾàǰ ȸ¼ö¿¡ °üÇÑ °øÇ¥
¾Ë¸²
[µ¿¾ÆÁ¦¾à]Å»¸ð»ó´ãÀÇ ÇØ´ä, Ä«ÇÊ·¯½º À̺¥Æ® GO¢º
¾Ë¸²
ÁøÅëÁ¦ ½À°ü Àâ´Â ±â¼ú! ʼ¾ »ó´ã °¡ÀÌµå ¹Þ±â ¢º
°øÇ¥
JW½Å¾à ÀǾàǰ(ÆÄ³ª´ýÅ©¸²) ȸ¼ö¿¡ °üÇÑ °øÇ¥
¾Ë¸²
Á¤¸Æ¼øÈ¯Àå¾Ö Ư°! ´Ù¸®º×±â? ´ºº£ÀÎ! ¸¶½ºÅÍÇϱ⠢º
¾Ë¸²
NCA ÁÖÄ¡¾à»ç 3±â ¸ðÁý!
D-107
ij³ª´Ù¾à»ç ½ÃÇè, ÀÌ·¸°Ô ¹Ù²ï´Ù! ( ~12.31 )
D-107
¾à¾÷°è ´ëÇ¥ ±³À°»çÀÌÆ®, ÆÊŬ·¡½º ( ~12.31 )
D-1
SGLT ¾ïÁ¦Á¦ ÇÙ½É º¹¾àÁöµµ ¢º»çÀü½Åû ( ~9.16 )
D-4
PV ¾÷¹«¿ª·® °È±³À° ¼ö°½Åû ¢º ( ~9.19 )
D-11
ÈѽºÅ»·Î Àд ¼ÒÈÁ¦ Æ®·»µå µî·Ï¢º ( ~9.26 )
¾à±¹°æ¿µ°ú â¾÷
¾à±¹Ã¢¾÷°ü·Ã
¼¼¹«»ó´ã
±Ç¸®±ÝÀ» ³ª´²¼ ½Å°í ÇÒ ¼ö µµ ÀÖ³ª¿ä?
ÀÚ»ê°ü¸®
Á¾½Åº¸Çè °è¾àÀÚ¿Ü ¼öÀÍÀÚ º¯°æ °¡´ÉÇѰ¡¿ä?
¹ý·ü»ó´ã
¸éÇã´ë¿©¾à±¹¿¡´ëÇÑ Áú¹®
¾à±¹´ëÃâ
¾à±¹¿î¿µÀÚ±Ý
¼¼¹«¡¤³ë¹«
(±Ù¹«¾à»ç ÁßµµÅð»ç) Ãß°¡ Áú¹®µå¸³´Ï´Ù
±³À° °Á ¹× ¾Ë¸² ±¤°í ¾È³» ÆäÀÌÁö
¿¬¼ö, ±³À°, ¼¼¹Ì³ª, Çмú°Á ¹× ±â¾÷±³À°, ¸ðÁý
°øÇ¥, Åä·Ðȸ, ÀǾàǰ º¯°æ ¾È³» ¹× °¢Á¾ Çà»ç
¾Ë¸² ±¤°í¸¦ ÇØµå¸³´Ï´Ù.
(Á¢¼ö ¹®ÀÇ ¹Ù·Î°¡±â)
¿À´ÃÀÇ
ÇÖ´º½º
1
ÇѾà»ç â°íÇü¾à±¹¿¡ ¹®Àü¾à±¹µµ °³¼³¡¦°¥µî °ÝÈ
2
À¯Åë¾÷üµµ À§°íºñ È¿°ú...ºí·ç¿¥ÅØ, ºñ±Þ¿© ¸ÅÃâ 2¹è¡è
3
¶á¼Ò¹®¿¡ ³¸® ³¯ ¸¸ Çϳ×...'¾Æ¸ñ½Ã½Ç¸°' ó¹æ ½ÃÀå 2õ¾ï
4
ÀÚµð¾Ó ³»´Þ 23ÀÏ Æ¯Ç㸸·á¡¦400°³ Á¦Ç° ½ñ¾ÆÁø´Ù
5
"°¡°Ý Â÷ÀÌ ¾ø³×"...ÇѾà»ç â°íÇü ¾à±¹ ¸¾Ä«Æä ¹ÝÀÀº¸´Ï
6
¾¾Æ¼¾¾¹ÙÀÌ¿À, ÇÑÁöºØ µÎ°¡Á· À¯ÁöµÉ±î¡¦º¯È °¨Áö
7
±â¼úµµÀÔ¡¤±¸Á¶Á¶Á¤ º´ÇࡦDXVX, üÁú °³¼± ¼Óµµ
8
¾à´ë ³í¼ú Àα⠻óÁ¾°¡...¾ÆÁÖ´ë 708´ë 1, ¼º´ë 515´ë 1
9
¹Ì±¹, ÃÖÇý±¹ ¾à°¡ ¾Ð¹Ú¡¦RSA¡¤ÀÌÁ߾డÁ¦ ¼ÕÁú ¿¹°í
10
ÀÌÁßÇ×ü¡¤ADC, Æó¾Ï ÀÓ»ó ¿¬ÀÌÀº ¼º°ú...»õ ¿É¼Ç û½ÅÈ£